22157.jpg
IVD Raw Materials Global Market Report 2022: Featuring Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck, F. Hoffmann-La Roche & Thermo Fisher
11 nov. 2022 08h08 HE | Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "IVD Raw Materials Market, By Product, By Technology, By End-User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028"...
22157.jpg
Global Companion Diagnostics Market Report 2022: Increasing Clinical Trials and Need for Next-Generation Sequencing to Drive Sector
07 nov. 2022 08h53 HE | Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Companion Diagnostics Market, By Product and Service, By Technology & By Region- Forecast and Analysis 2022-28" report has been added to ...
22157.jpg
Companion Diagnostics Global Market to Reach $9.99 Billion by 2026 at a CAGR of 18.01%
29 sept. 2022 08h23 HE | Research and Markets
Dublin, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The "Companion Diagnostics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global companion diagnostics market...
Global Minimal Residual Disease (MRD) Testing Market Research Report 2022
22 juin 2022 06h53 HE | Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Global MRD Testing Market: Focus on Technology, Application, End User, Region - Analysis and Forecast, 2022-2027" report has been added to...
Press release Biocartis Group NV: Biocartis Announces New Agreement with AstraZeneca for the Development and Marketing of a Companion Diagnostic Test for Tagrisso®
22 juin 2022 01h00 HE | Biocartis NV
PRESS RELEASE: 22 June 2022, 07:00 CEST Biocartis Announces New Agreement with AstraZeneca for the Development and Marketing of a Companion Diagnostic Test for Tagrisso® Mechelen, Belgium, 22 June...
Persbericht Biocartis Group NV: Biocartis kondigt nieuwe overeenkomst aan met AstraZeneca voor de ontwikkeling en marketing van een companion diagnostic test voor Tagrisso®
22 juin 2022 01h00 HE | Biocartis NV
PERSBERICHT: 22 juni 2022, 07:00 CEST Biocartis kondigt nieuwe overeenkomst aan met AstraZeneca voor de ontwikkeling en marketing van een companion diagnostic test voor Tagrisso® Mechelen, België,...
22157.jpg
Global Diagnostics Partnering Deals Analysis 2015-2022: Analysis of How and Why Companies Enter Diagnostics Partnering Deals
13 juin 2022 04h23 HE | Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Global Diagnostics Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Global Diagnostics...
22157.jpg
Global Companion Diagnostics Partnering Deal Analysis 2010-2022: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target, Technology Type
13 juin 2022 04h18 HE | Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Global Companion Diagnostics Partnering Terms and Agreements 2010-2022" report has been added to ResearchAndMarkets.com's offering. The Global...
22157.jpg
The Worldwide Multiplex Assay Industry is Expected to Reach $4 Billion by 2027
18 mai 2022 05h23 HE | Research and Markets
Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "Global Multiplex Assay Market Size, Share & Industry Trends Analysis Report By Product, By Type, By End user, By Application (Research &...
22157.jpg
Companion Diagnostics Development Services Markets, 2035
10 mai 2022 04h28 HE | Research and Markets
Dublin, May 10, 2022 (GLOBE NEWSWIRE) -- The "Companion Diagnostics Development Services Market: Distribution by Type of Service Offered, Analytical Technique Used, Therapeutic Areas and Key...